Sanara Medtech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $27,798 | $27,545 | $26,333 | $25,830 |
Gross Profit | 25,287 | 25,002 | 23,848 | 23,893 |
EBITDA | 3,233 | 3,559 | 3,572 | 1,082 |
EBIT | 2,646 | 2,891 | 2,961 | -31 |
Net Income | 458 | -1,609 | -30,411 | -2,014 |
Net Change In Cash | 27,798 | 27,545 | 26,333 | 25,830 |
Free Cash Flow | -2,509 | 3,862 | 1,116 | 902 |
Cash | 13,594 | 16,578 | 14,939 | 16,958 |
Basic Shares | 8,985 | 8,623 | 8,940 | 8,612 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $103,117 | $86,672 | $64,989 | $45,842 |
Gross Profit | 92,935 | 78,532 | 57,137 | 39,481 |
EBITDA | 11,807 | -1,860 | -289 | -11,566 |
EBIT | 9,145 | -6,783 | -3,964 | -13,937 |
Net Income | -37,562 | -9,664 | -4,303 | -7,937 |
Net Change In Cash | 103,117 | 86,672 | 64,989 | 45,842 |
Cost of Revenue | -9,693 | |||
Free Cash Flow | 2,160 | -253 | -3,510 | -6,301 |
Cash | 16,578 | 15,878 | 5,147 | 8,958 |
Basic Shares | 8,623 | 8,484 | 8,278 | 7,906 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0.04 |
2025-12-31 | -$0.19 |
2025-09-30 | -$3.40 |
2025-06-30 | -$0.23 |